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Purpose: Emerging evidence suggests cardiac substructures are highly radiosensitive during radiation therapy for
cancer treatment. However, variability in substructure position after tumor localization has not been well
characterized. This study quantifies inter-fraction displacement and planning organ at risk volumes (PRVs) of
substructures by leveraging the excellent soft tissue contrast of magnetic resonance imaging (MRI).
Methods: Eighteen retrospectively evaluated patients underwent radiotherapy for intrathoracic tumors with a
0.35 T MRI-guided linear accelerator. Imaging was acquired at a 17–25 s breath-hold (resolution 1.5 × 1.5 × 3
mm3). Three to four daily MRIs per patient (n = 71) were rigidly registered to the planning MRI-simulation based
on tumor matching. Deep learning or atlas-based segmentation propagated 13 substructures (e.g., chambers,
coronary arteries, great vessels) to daily MRIs and were verified by two radiation oncologists. Daily centroid
displacements from MRI-simulation were quantified and PRVs were calculated.
Results: Across substructures, inter-fraction displacements for 14% in the left–right, 18% in the anterior-posterior,
and 21% of fractions in the superior-inferior were > 5 mm. Due to lack of breath-hold compliance, ~4% of all
structures shifted > 10 mm in any axis. For the chambers, median displacements were 1.8, 1.9, and 2.2 mm in the
left–right, anterior-posterior, and superior-inferior axis, respectively. Great vessels demonstrated larger dis
placements (> 3 mm) in the superior-inferior axis (43% of shifts) and were only 25% (left–right) and 29%
(anterior-posterior) elsewhere. PRVs from 3 to 5 mm were determined as anisotropic substructure-specific
margins.
Conclusions: This exploratory work derived substructure-specific safety margins to ensure highly effective cardiac
sparing. Findings require validation in a larger cohort for robust margin derivation and for applications in
prospective clinical trials.

1. Introduction

independent predictors of a patients’ quality of life [6] and overall
survival [5]. Yet, the heart is complex and dose to substructures (e.g.,
coronary arteries, ventricles, atria, great vessels, etc.) contained within
the heart have been strongly linked to radiation-induced cardiac
morbidity [7] and future acute coronary events [8,9]. Thus, recent
attention has been focused toward local radiation dose deposition to
substructures contained within the heart. Sub-analysis of RTOG 0617
revealed that atrial, ventricular, and pericardial doses had a stronger

Radiation therapy (RT) doses to the heart are strongly linked to
cardiotoxicities such as coronary heart disease, heart failure, and even
cardiac death [1]. Cardiotoxicity is often reported for breast, lung, and
esophageal cancers as well as Hodgkin’s disease [2–4]. In RTOG 0617
[5], evaluating dose escalation for locally advanced non-small cell lung
cancer (NSCLC) volumes of the heart receiving ≥ 5 and ≥ 30 Gy were
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treatment (11 imaged in end-exhalation (EE) and 7 in end-inhalation
(EI)). Breath-hold scans were conducted using a 17 to 25-second
acquisition time (1.5–1.6 × 1.5–1.6 × 3.0 mm3 resolution, echo times
1.3–1.6 ms, repetition time 3–3.8 ms, bandwidth 385–599 Hz/Px,
generalized auto-calibrating partially parallel acquisitions (GRAPPA) =
2). For each acquisition, a balanced steady state free precession
sequence was utilized (TrueFISP, Siemens, MAGNETOM Avanto, Syngo
MR B19). All acquisitions were two-dimensional and TrueFISP is
commonly used in cardiac imaging due to its high signal-to-noise ratio
and imperviousness to motion artifacts [18,19] as well as being inte
grated in the MR-linac clinical offerings.

association with overall survival than using standard whole heart dose
metrics [10].
However, one significant challenge with assessing dose to cardiac
substructures is that they are not typically considered in the treatment
planning process as they are difficult to discern on non-contrast treat
ment planning CTs due to limited soft tissue contrast. MRI, on the other
hand, substantially improves substructure visibility [11,12]. Magnetic
resonance-guided RT (MRgRT) offers significant advantages compared
to x-ray based technologies for delineation, localization, tumor tracking,
and adaptive RT. Tumor and organ at risk (OAR) visualization using
0.35 T MRgRT has been shown to be superior to cone-beam computed
tomography (CBCT) [13]. MRgRT allows for simultaneous tracking to
monitor intra-fraction motion during treatment delivery [14] while
avoiding radiation exposure due to the continuous imaging.
In a prospective Phase 1 trial for adaptive MRgRT for ultra-central
lung cancer, the proximity of the lesion to the heart triggered plan
adaptation for multiple treatment fractions, suggesting that interfraction displacement of the heart may be substantial [15]. Prior
studies have shown that the average inter-fraction displacements of the
heart and the left anterior descending artery (LADA) are typically < 7
mm in each axis with the superior-inferior (S-I) displacement typically
being the greatest due to diaphragm motion [16,17]. To date, limited
data are available to quantify inter-fraction displacement of other sub
structures other than the LADA. This study sought to leverage longitu
dinal MRgRT data to quantify inter-fraction displacements of 13 cardiac
substructures to facilitate safety margin design.

2.2. Cardiac substructure segmentation
Inter-fraction motion was assessed for 13 cardiac substructures
including the whole heart, left/right atria (LA, RA), ventricles (LV, RV),
superior/inferior venae cavae (SVC, IVC), ascending aorta (AA), pul
monary artery/veins (PA, PV), LADA, right coronary artery (RCA), and
left main coronary artery (LMCA). Of the 18 patients studied, initial
substructure segmentations were generated on MR-SIM datasets using a
previously validated segmentation atlas [20] for 9 patients. For the
remaining 9 patients, substructures were automatically generated using
a three-dimensional deep learning U-Net [21] that was developed at a
later date. The deep learning U-Net was implemented as it improved
segmentation accuracy and efficiency as compared to the atlas. After the
substructures were segmented on the initial MR-SIM dataset, the
outputted segmentations were validated by a radiation oncologist.
Contours underwent final verification by the more experienced of the
two radiation oncologists with manual modifications made as needed to
ensure clinically viable segmentations were rendered regardless of the
initial segmentation approach.
A commercially available intensity-based free-form deformable
image registration algorithm (MIM Software, Cleveland, OH) was used
to propagate contours from the MR-SIM to each daily MRI, yielding a
total of 3–4 registrations per patient (71 unique daily MRIs across all
patients). Final propagated contours were again verified by one of two
radiation oncologists and corrected as needed. To assess the interfraction substructure displacement due to daily patient positioning, a
final translation-only rigid registration between the MR-SIM image and
each daily MRI was performed by a physicist with an emphasis on
aligning the planning target volumes (PTVs).

2. Materials and methods
2.1. Patient methods for low-field MRI
Eighteen patients who underwent daily MRgRT using a ViewRay
MRIdian 0.35 T MR-linac (ViewRay, Mountain View, CA) were retro
spectively analyzed on an Institutional Review Board approved protocol.
Eleven patients had lung masses (64% metastatic and 36% primary
malignancies), three had mediastinal and chest wall lesions, and four
patients had hepatocellular carcinoma. Stereotactic body RT (SBRT) was
prescribed to 14/18 of the study cohort (4–5 fractions/patient) and the
remaining were treated with conventionally fractionated intensity
modulated RT (14–30 fractions/patient). All cases underwent MRsimulation (MR-SIM) in the same respiratory condition used for

Table 1
Heart and substructure displacements for all studied MRI guided radiation therapy fractions with respect to the MRI simulation image. Abbreviations Left-Right (L-R),
Anterior-Posterior (A-P), Superior-Inferior (S-I), and millimeter (mm).
Structure
Heart (median (range) mm))
% within 10 mm
% within 5 mm
LV/RV
LA/RA
Great Vessels
LADA
RCA
LMCA

Displacements
L-R

A-P

S-I

Vector

2.0 (0.2–6.9)
100
94
2.4 (0.1–15.1)
96
84
2.6 (0.1–11.4)
97
82
2.1 (0.0–13.3)
97
87
2.7 (0.0–19.3)
94
78
2.9 (0.0–14.8)
96
73
3.0 (0.0–22.2)
96
82

1.1 (0.0–6.5)
100
90
2.2 (0.0–15.6)
98
80
1.7 (0.0–13.9)
97
84
1.8 (0.0–13.8)
98
85
3.3 (0.1–17.3)
92
66
2.5 (0.0–16.0)
93
76
2.3 (0.0–15.3)
96
86

2.7 (0.2–9.2)
100
84
2.1 (0.0–10.9)
97
82
2.5 (0.0–14.0)
96
82
2.6 (0.0–10.8)
99
80
2.8 (0.1–19.8)
94
69
3.2 (0.0–11.3)
94
73
2.8 (0.0–12.1)
96
79

4.4
94
58
5.2
88
49
5.1
89
49
4.9
93
51
6.6
73
32
6.4
79
41
5.6
89
44
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(1.5–11.2)
(0.3–17.6)
(0.5–21.3)
(0.3–18.1)
(1.4–22.6)
(1.2–22.8)
(0.6–25.8)

E.D. Morris et al.

Physics and Imaging in Radiation Oncology 18 (2021) 34–40

Fig. 1. (Top row) Left anterior descending artery (LADA) and (bottom row) left ventricle (LV) displacement across all treatment fractions for the patient population
with respect to positioning at MR-simulation across each cardinal axis. The box represents the interquartile range with the median denoted as the bold horizontal line.
The whiskers represent the maximum and minimum with the exception of outliers, i.e. circles and stars, which represent 1.5 and 3 times the interquartile range,
respectively.

For a subset of patient cases, the impact of displacement on the dose
to that particular substructure was evaluated by mapping the initial
physician-approved treatment planned dose through the translationonly rigid registration between the MR-SIM and daily MRI. Dose was
not adapted or recalculated to best represent an image-guided radiation
therapy (IGRT) workflow.

3. Results
3.1. Patient population results
Across substructures, inter-fraction displacements for 14% (left–
right (L-R)), 18% (anterior-posterior (A-P)), and 21% (S-I) fractions
were > 5 mm. Table 1 summarizes the excursions across the patient
population for all cardiac substructures in the L-R, A-P, S-I, and vector
displacements. Less than 4% of all substructures displaced 10 mm in any
axis. For the chambers, the median absolute displacements were 1.8 (LR), 1.9 (A-P), and 2.2 mm (S-I). The RCA shifted similarly in all axes
(median shifts: 2.5–3.0 mm), whereas the LADA had the highest A-P, S-I,
and vector shifts of all substructures evaluated. The great vessels (i.e.
SVC, PA, and AA) showed a tendency to have larger displacements in the
S-I axis, with 43% of shifts being > 3 mm, whereas only 25% and 29% of
displacements were observed in the L-R and A-P axes, respectively.
Fig. 1 shows the absolute centroid shifts from the MR-SIM for the LV
and LADA across all four fractions for the patient population. Patients 7
and 9 exhibited the largest shifts (>10 mm) in the L-R axis for the LV.
Fig. 2 highlights Patient 7, who underwent SBRT to a mediastinal lymph
node, with marked movement of the LV, RV, LADA, RCA and RA due to
lack of breath-hold compliance. Patient 9 (Fig. 2, bottom) underwent RT
for a left lower lung lesion and exhibited the largest displacement of the
LV between MR-SIM and Fraction 4 in the L-R axis. This patient was also
unable to reproduce an EE breath-hold, leading to clear displacements in
resulting substructure locations.
While most LADA shifts shown in Fig. 1 were < 10 mm, Fraction 3
for Patient 5 (SBRT to pulmonary nodule) exhibited an LADA centroid
shift > 18 mm with Fig. 3 displaying the axial and sagittal axes at the
centroid of the LADA with the planned treatment dose. Note the marked
movement of RV, LV, and LADA displacement, particularly in the infe
rior direction, moving the substructures further away from the high dose
region.
Patient 18 who underwent SBRT for a liver dome hepatocellular
carcinoma also struggled with breath-hold compliance as highlighted in
Fig. 4. As Fig. 1 shows, Patient 18 had the largest centroid displacement
for the LV in the A-P axis and exceeded LV shifts across the population in
the A-P by > 5 mm. The dose volume histogram (DVH) shown in Fig. 4

2.3. Data extraction and pooling
A MIM workflow was developed to export centroid and volume in
formation for the substructures after tumor-based rigid registrations.
Inter-fraction differences for each cardiac substructure were quantified
via centroid analysis in each cardinal axis and total vector displace
ments. Data pooling was performed across all 18 patients (3–4 fractions/
patient) as all data were acquired under breath-hold conditions. As data
were not normally distributed as determined by a Shapiro-Wilk test,
descriptive population statistics were presented via medians, ranges,
box plots. All statistical analysis was performed using SPSS version 27.0
(SPSS, Chicago, IL, USA).
2.4. Planning organ at risk volume generation
ICRU 62 recommends the inclusion of margins for OARs (e.g.,
planning organ at risk volume (PRV)) to account for systematic and
random uncertainties in RT [22,23]. Using the MR-SIM as the reference,
mean and standard deviation (SD) of the centroid displacements for each
patient and substructure were calculated. The systematic error (Σ) was
calculated by taking the SD of the mean displacement and the random
error (σ) was determined by calculating the root-mean-square of the SD
[24]. Uncertainty induced by respiration [25] was not included in this
calculation as patients studied were treated in breath-hold conditions.
The PRV was calculated to accommodate daily setup variations based on
McKenzie et al. [23] with coefficients selected where the maximum dose
to the PRV did not exceed the OAR maximum dose in 90% of cases
[23,25] as described in Equation (1):
PRV = 1.3*Σ + 0.5*σ

(1)
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Fig. 2. Patients 7 (top row) and 9 (bottom row) who
experienced large left–right shifts between MRsimulation (SIM) (left) and daily treatment fraction
4 (Fx4) (right). For each patient, both axial and cor
onal views are displayed for both the MR-simulation
and the daily treatment. The inferior aspect of the
lung contours highlights the lack of breath-hold
compliance with the initial MR-simulation condition
despite verbal coaching being implemented. Cardiac
substructure abbreviations: RV – right ventricle, LV –
left ventricle, RA – right atrium, IVC – inferior vena
cava, LADA – left anterior descending artery, RCA –
right coronary artery, LA – left atrium, AA – ascending
aorta, SVC – superior vena cava, PA – pulmonary
artery.

Fig. 3. Displacement of cardiac substructures and planned dose between the 0.35T MR-simulation (SIM) on axial (top row) and sagittal (bottom row) axes compared
to fraction 3 (Fx3) 0.35T MRI for Patient 5 undergoing stereotactic body radiation therapy for a pulmonary nodule. Cardiac substructure abbreviations: RV – right
ventricle, LV – left ventricle, RA – right atrium, LA – left atrium, AA – ascending aorta, LADA – left anterior descending artery, RCA – right coronary artery, PV –
pulmonary vein.
37
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Fig. 4. Top Row: Displacement of cardiac substructures and planned dose between MR-simulation (SIM) in an axial view compared to fraction 2 (Fx2) MR for Patient
18 receiving stereotactic body radiation therapy for anterior liver dome hepatocellular carcinoma. Bottom: Dose Volume Histogram (DVH) showing planning dose to
cardiac substructures and the planning target volume (PTV) at both timepoints with higher substructure doses apparent in Fraction 2. Cardiac substructure ab
breviations: RV – right ventricle, LV – left ventricle, RA – right atrium, IVC – inferior vena cava, LADA – left anterior descending artery, RCA – right coronary artery,
LA – left atrium, AA – ascending aorta, SVC – superior vena cava, PA – pulmonary artery.

highlights that after tumor localization, fraction 2 resulted in higher
substructure doses (e.g., mean IVC dose increased by 3.6 Gy) when
compared to the planned dose.

3.2. Planning organ at risk volume calculation
Table 2 summarizes the calculated systematic and random errors
across cardiac substructures, as well as the resulting PRV calculated
according to Equation (1). As shown by Table 2, an isotropic margin of 4
mm was determined for the LV. The largest isotropic margin of 5 mm
was calculated for the LADA. The great vessels and RV experienced the
smallest PRVs with the majority of axes being 3 mm.

Table 2
Systematic (left) and random error (center) used to calculate the planning organ
at risk volume (PRV) margins (right) across 12 cardiac substructures for the
population (n = 18). Abbreviations: L-R – left–right, A-P – anterior-posterior, S-I
– superior-inferior, LV – left ventricle, LA – left atrium, RV – right ventricle, RA –
right atrium, PV – pulmonary vein, PA – pulmonary artery, AA – ascending
aorta, SVC – superior vena cava, IVC – inferior vena cava, RCA – right coronary
artery, LADA – left anterior descending artery, LMCA – left main coronary
artery.
Substructure

LV
LA
RV
RA
PV
PA
AA
SVC
IVC
RCA
LADA
LMCA

4. Discussion
By leveraging the soft tissue contrast of MRgRT, this work sought
to quantify inter-fractional displacements of 13 sensitive cardiac sub
structures over the SBRT treatment course. Centroid shifts over longi
tudinal MRgRT data were analyzed and PRV margins were calculated.
Overall, after tumor alignment, inter-fraction displacement of individual
substructures varied with the largest deviations arising from a lack of
breath-hold compliance. Derived PRV margins were substructurespecific and ranged from 3 to 5 mm with select substructures
requiring anisotropic margins.
While inter-fraction whole heart displacements have been charac
terized in the literature, limited data are available for substructure
comparisons. Alderliesten et al. included breast cancer patients who
received adjuvant whole-breast RT at deep inspiration breath-hold
(DIBH) [16]. The heart position relative to the breast surface, as
captured by surface imaging with AlignRT system, was measured with a
planning CT and daily CBCTs. Based on data from 378 fractions of 20

PRV (mm)

Systematic Error
Σ (mm)

Random Error
σ (mm)

L-R

A-P

S-I

L-R

A-P

S-I

L-R

A-P

S-I

2.3
2.4
2.3
1.9
2.1
2.0
2.2
1.8
1.3
2.5
2.9
2.2

2.3
2.3
1.9
2.0
1.7
1.4
1.8
2.3
2.0
2.3
2.7
1.9

2.1
2.9
1.7
2.1
1.7
1.9
2.0
1.5
2.7
2.1
2.8
2.1

2.2
1.8
1.8
1.6
2.4
2.0
1.7
1.7
2.1
2.1
2.5
3.3

2.4
2.1
2.1
2.2
2.0
2.1
2.0
1.8
2.0
3.0
3.4
2.5

2.0
1.8
1.9
2.1
2.0
1.9
2.0
2.2
2.6
2.4
2.5
2.2

4
4
4
3
4
4
4
3
3
4
5
5

4
4
3
4
3
3
3
4
4
5
5
4

4
5
3
4
3
3
4
3
5
4
5
4
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patients, the displacement of the heart was 2.1 ± 2.0 (L-R), 0.8 ± 3.3 (AP), and − 2.2 ± 7.8 mm (S-I) [16]. Our work yielded heart displacements
of similar magnitude (2.3 ± 1.5 (L-R), 1.7 ± 1.7 (A-P), and 3.1 ± 2.4 mm
(S-I)). Jagsi et al. investigated the inter-fraction reproducibility of the
LADA for 10 patients who underwent adjuvant RT for breast cancer
under active breathing control [17]. The displacements of the LADA
from the planning CT scan to that from 11 treatment fractions were
assessed at EE after a bony image registration based on the spine. Longterm reproducibility of the LADA position, defined as the SD, was 4.5 (LR), 3.3 (A-P), and 6.0 mm (S-I) at EE [17]. In the present study, the
displacement of the LADA was 3.6 ± 3.6 (L-R), 4.4 ± 3.8 (A-P), and 3.8
± 3.5 mm (S-I) which are similar to the values reported by Jagsi et al.
[17]. Our study further adds to the literature by including 13 sub
structures and having the added benefit of the soft tissue contrast pro
vided by the on-board 0.35 T MRI.
PRVs for 13 cardiac substructures were calculated in this study. Li
et al. utilized 20-phase electrocardiogram gated data and a reference of
the end-systolic phase to determine coronary artery PRVs [24] using the
same margin calculation [23] as in our work, and found PRV margins
between 3 and 8 mm. Similarly, Topolnjak et al. studied the geometrical
uncertainty of the heart using CBCT datasets for left-sided breast cancer
patients [25]. They calculated PRVs from inter-fractional displacement
of the whole heart to be 1.6, 1.4, and 2.1 mm in the L-R, A-P, and S-I
axes, respectively. The values from these two studies are of similar
magnitude (3–5 mm) of PRVs derived in the current study. The
discrepancy from Li et al. is likely due to their coronary artery seg
mentations being standardized at 2 mm diameter, whereas our coronary
artery segmentations were not standardized and tended to be ~ 4 mm. In
the present study, the largest PRV margins were found in the S-I axis,
likely due to the larger slice thickness (3 mm) of MRI acquisition.
One limitation of our study is that the low-field MRIs were not car
diac gated and therefore were not able to take cardiac motion into
consideration. As the image acquisition time ranged from 17 to 25 s,
numerous cardiac cycles were captured throughout the course of im
aging and therefore, it is expected that the substructures are represented
by their average position over the scan acquisition. The presence of
cardiac motion may have presented challenges in identifying the coro
nary arteries as they may become indistinct and noncontiguous with
motion [26]. Although cardiac motion may be on the order of 3–8 mm
[27], it is currently not taken into consideration during RT treatment
delivery or in the clinical evaluation of dose as dedicated adjunct cineangiography or echocardiography would be required for adequate
characterization. To accommodate cardiac motion in the PRV design, a
method followed by Topolnjak et al. that incorporated an additional
term for respiratory motion could be implemented [25]. This was not
addressed in this work as patients were treated under breath-hold
conditions.
Another limitation of this work is that only 0.35 T TrueFISP MRgRT
datasets were evaluated. Cardiac substructure identification may be
further identified using complementary datasets such as functional MRI,
late gadolinium enhancement, and cine images [28]. To translate to
other field strengths (e.g., 1.5 T Unity MR-linac (Elekta AB, Stockholm,
Sweden)), the deep learning segmentation pipeline would need to be
retrained for the higher field MRI datasets for the desired sequence.
Nevertheless, it is expected that the inter-fraction substructure dis
placements quantified for low-field MRI may be applied regardless of
field strength.
Our previous work found that integrating cardiac substructures into
the re-optimization of retrospective thoracic RT plans drastically
reduced dose to sensitive substructures with a negligible increase in plan
complexity while maintaining other clinical dosimetric endpoints [29].
Cardiac substructure sparing via volumetric modulated arc therapy was
shown by Ferris et al. who achieved significant improvements in mean
dose to the chambers, great vessels, and coronary arteries [30]. These
studies underscore the importance in considering cardiac substructures
in planning which will also require adequate setup and motion margin

consideration.
Our work revealed that anisotropic cardiac substructure-specific
PRVs may be warranted to accommodate inter-fractional shifts. Pa
tients who are unable to comply with breath-hold conditions may
benefit from patient-specific substructure margins. These results can be
confirmed in a larger cohort stratified by respiratory status and further
accounting for systematic and random uncertainties for clinical trial
integration. This study can be further expanded by exploring relational
changes of specific cardiac substructures with respect to others evalu
ated and across different patients.
In conclusion, this work quantified the inter-fraction displacement of
cardiac substructures to derive safety margins to ensure highly effective
cardiac sparing. Individual cardiac substructure displacement demon
strated variability in magnitude and dominant axis, suggesting that
anisotropic substructure-specific PRVs may be warranted. These find
ings require validation in a larger cohort for applications in prospective
clinical trials.
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